Effects of (5Z)-7-Oxozeaenol on the oxidative pathway of cancer cells

Anticancer Research

Volumn 32, Issue 7, 2012, Pages 2665-2671

  Acuña, Ulyana Muñoz ^a   Wittwer, Jennifer ^a   Ayers, Sloan ^b   Pearce, Cedric J ^c   Oberlies, Nicholas H ^b   Carcache De Blanco, Esperanza J ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^c Mycosynthetix   (United States)

Author keywords

(5Z) 7 Oxozeaenol; Apoptosis; Caspase; HeLa; HT 29 cells; Ikk ; IKK ; NF B pathway; ROS

Indexed keywords

7 OXOZEAENOL; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 7; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PACLITAXEL; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

CASPASE 3; CASPASE 7; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; HELA CELLS; HT29 CELLS; HUMANS; IMMUNOBLOTTING; MEMBRANE POTENTIAL, MITOCHONDRIAL; NF-KAPPA B; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; UTERINE CERVICAL NEOPLASMS; ZEARALENONE;

EID: 84865694077     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Perkins ND: Integrating cell-signalling pathways with NFkappaB and IKK function. Nat Rev Mol Cell Biol 8: 49-62, 2007.
2. Yin Y, Chen X, and Shu Y: Gene expression of the invasive phenotype of TNF-alpha-treated MCF-7 cells. Biomed Pharmacother 63: 421-428, 2009.
3. Darnell JE: Transcription factors as targets for cancer therapy. Nat Rev Cancer 2: 740-749, 2002.
4. Lerebours F, Vacher S, Andrieu C, Espie M, Marty M, Lidereau R and Bieche I: NF-kappa B genes have a major role in inflammatory breast cancer. BMC Cancer 8: 41, 2008.
5. Ayers S, Graf TN, Adcock AF, Kroll DJ, Matthew S, Carcache de Blanco EJ, Shen Q, Swanson SM, Wani MC, Pearce CJ and Oberlies NH: Resorcylic Acid Lactones with Cytotoxic and NF-kappaB Inhibitory Activities and Their Structure Activity Relationships. J Nat Prod 74: 1126-1131, 2011.
6. Ninomiya-Tsuji J, Kajino T, Ono K, Ohtomo T, Matsumoto M, Shiina M, Mihara M, Tsuchiya M and Matsumoto K: A resorcylic acid lactone, (5Z)-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. J Biol Chem 278: 18485-18490, 2003.
7. Takaesu G, Surabhi RM, Park KJ, Ninomiya-Tsuji J, Matsumoto K and Gaynor RB: TAK1 is critical for IkappaB kinase-mediated activation of the NF-kappaB pathway. J Mol Biol 326: 105-115, 2003.
8. Sakurai H, Suzuki S, Kawasaki N, Nakano H, Okazaki T, Chino A, Doi, T and Saiki I: Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. J Biol Chem 278: 36916-36923, 2003.
9. Omori E, Morioka S, Matsumoto K and Ninomiya-Tsuji, J: TAK1 regulates reactive oxygen species and cell death in keratinocytes, which is essential for skin integrity. J Biol Chem 283: 26161-26168, 2008.
10. Goto M, Chow J, Muramoto K, Chiba K, Yamamoto S, Fujita M, Obaishi H, Tai K, Mizui Y, Tanaka I, Young D, Yang H, Wang YJ, Shirota H and Gusovsky F: E6201 [(3S,4R,5Z,8S,9S,11E)-14-(ethylamino)-8, 9,16-trihydroxy-3,4-dimethyl-3,4,9,19- tetrahydro-1H-2-benzoxacyclotetradec ine-1,7(8H)-dione], a novel kinase inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK)-1 and MEK kinase-1: in vitro characterization of its anti-inflammatory and antihyperproliferative activities. J Pharmacol Exp Ther 331: 485-495, 2009.
11. Eisen A, Akerele C, Reyderman L, Verbel DA, Simon JS, Davis DW, Nomoto K and Wang J: CTC biomarker assessment to aid dosing selection of E6201, a potential MEK1 inhibitor, for treatment of BRAF-mutated melanoma. Ann Oncol 21: 405-405, 2010.
12. Shen Y, Boivin R, Yoneda N, Du H, Schiller S, Matsushima T, Goto M, Shirota H, Gusovsky F, Lemelin C, Jiang Y, Zhang Z, and Pelletier R, Ikemori-Kawada M, Kawakami Y, Inoue A, Schnaderbeck M, Wang, Y: Discovery of anti-inflammatory clinical candidate E6201, inspired from resorcylic lactone LL-Z1640-2, III. Bioorg Med Chem Lett 20: 3155-3157, 2010.
13. Muramoto K, Goto M, Inoue Y, Ishii N, Chiba K, Kuboi Y, Omae T, Wang YJ, Gusovsky F and Shirota H: E6201, a novel kinase inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-1 and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase-1: in vivo effects on cutaneous inflammatory responses by topical administration. J Pharmacol Exp Ther 335: 23-31, 2010.
14. Deng Y, Balunas MJ, Kim JA, Lantvit DD, Chin YW, Chai H, Sugiarso S, Kardono L B, Fong H H, Pezzuto JM, Swanson SM, Carcache de Blanco EJ and Kinghorn AD: Bioactive 5,6-dihydro-alpha-pyrone derivatives from Hyptis brevipes . J Nat Prod 72: 1165-1169, 2009.
15. Kim JA, Lau EK, Pan L and Carcache de Blanco EJ: NF-kappaB inhibitors from Brucea javanica exhibiting intracellular effects on reactive oxygen species. Anticancer Res 30: 3295-3300, 2010.
16. Fabre C, Carvalho G, Tasdemir E, Braun T, Ades L, Grosjean J, Boehrer S, Metivier D, Souquere S, Pierron G, Fenaux P and Kroemer G: NF-kappaB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia. Oncogene 26: 4071-4083, 2007.
17. Mauro C, Leow SC, Anso E, Rocha S, Thotakura AK, Tornatore L, Moretti M, De Smaele E, Beg AA, Tergaonkar V, Chandel NS and Franzoso G: NF-kappaB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration. Nat Cell Biol 13: 1272-1279, 2011.